Novo CEO pressed by Senate to chop rates of being overweight, diabetic issues medicines CEO Lars Fruergaard Jørgensen explained to lawmakers the company would consider new talks with insurers in regards to the list rates of Wegovy and copyright if they pledge to help keep the medicines on their own https://zanexxwwt.like-blogs.com/30527606/about-healthcare-news